Mo Li, PhD

Mo Li, PhD is a research fellow in the Department of Internal Medicine at the University of Michigan. After obtaining his B.S. degree from Northeastern Agriculture University in China in 2005, he finished his PhD at Chinese Academy of Sciences in 2010. After that, he joined Dr. Xiaochun Yu’s lab in University of Michigan to study DNA damage and repair in tumorigenesis both in vitro and in vivo. His current research interest focuses on the mechanism of PARP inhibitors on the therapy of ovarian cancer, and the relationship with BRCA1 in ovarian cancer. By using a combination of biochemistry and mouse model, Mo hopes to uncover how PARP inhibitors kill the tumor cells and predict the efficacy of PARP inhibitors on ovarian cancers with different BRCA1 mutations.